Currently, only 20 percent of US cataract patients receive toric IOLs to eliminate ocular astigmatism – but 40 percent of people over 60 have astigmatism of 1D or higher, making them candidates for toric IOLs. This low rate of toric IOL adoption is partly due to the lack of simple, accurate, and affordable instruments for toric IOL alignment.
To answer this unmet need, Keen Sight, Inc. has developed a new, highly accurate tool – the Polaris Keratoscope. This novel, microscope-mounted intraoperative diagnostic device is designed to guide cataract surgeons through toric IOL implantation. Employing a patented design, Polaris Keratoscope intraoperatively measures and displays the anterior cornea astigmatism angle in real-time with 1° accuracy, providing precise surgical guidance for toric IOL alignment on touchscreen display. The device provides retro-illumination for optimum visibility of toric marks.
Polaris Keratoscope’s high accuracy and ease of use aim to increase the adoption rate of toric IOL technology by cataract surgeons. Keen Sight, Inc. is dedicated to the development of new innovative ophthalmic devices to improve vision and quality of life for millions of people.
This product is currently FDA-listed and available for sale in the US. It is manufactured in California, USA.
